Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Shannon Turley - Vice President Senior Fellow - Cancer Immunology Discovery, Cancer Immunology

Shannon Turley

Vice President Senior Fellow - Cancer Immunology Discovery, Cancer Immunology

Postdoc Mentor
"The immunotherapy revolution in the fight against cancer has just begun. To fully harness the power of the immune system to destroy different types of cancers requires a much deeper understanding of the molecular and spatial relationships between lymphocytes and tumors. This is our charge."
Years at Genentech
Awards & Honors

I moved to Genentech in 2014 from Dana Farber Cancer Institute and Harvard Medical School. I had been a faculty member there for over a decade, focusing on immunology and stromal biology research. The decision to leave a dynamic academic mecca to carry out my research at Genentech was inspired by the tremendous opportunity to apply principles established in rigorous basic science to making real-life medicines. As a basic scientist, there’s no better place to be involved in the process of developing an immunotherapy from A to Z that may positively impact patient outcomes than Genentech.

Postdoctoral Mentor

For me, being a postdoc mentor is about the incredible satisfaction from doing cutting-edge science with eager, smart, determined and creative trainees while encouraging them to reach their potential. It is also about giving back to the scientific community by teaching the next generation of investigators, sharing my experiences and expertise, and nurturing their careers. I am honored to have the opportunity to serve as a mentor in Genentech’s world-class postdoctoral program and fortunate to also learn from these talented trainees, both in the laboratory and beyond. They are a select group of outstanding scientists.


Featured Publication

Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.

Cancer Discov. 2020 Feb;10(2):232-253.

Dominguez CX, Müller S, Keerthivasan S, Koeppen H, Hung J, Gierke S, Breart B, Foreman O, Bainbridge TW, Castiglioni A, Senbabaoglu Y, Modrusan Z, Liang Y, Junttila MR, Klijn C, Bourgon R, Turley SJ.